about
MR spectroscopy indicates diffuse multiple sclerosis activity during remissionOligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and RepairThe multifaceted role of astrocytes in regulating myelinationRemyelination Therapy in Multiple SclerosisHypersensitivity Responses in the Central Nervous SystemThe Role of Astrocytes in Multiple Sclerosis ProgressionAstrocytes: the missing link in neurologic disease?Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overviewPromoting remyelination in multiple sclerosis-recent advancesAstrocytes in multiple sclerosis: a product of their environmentThe astrocyte in multiple sclerosis revisitedRole of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytesInvolvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expressionPoor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter diseaseBlockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissueS100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase: IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTHAstrocyte galectin-9 potentiates microglial TNF secretionAstrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelinationExtreme retinal remodeling triggered by light damage: implications for age related macular degeneration.Physical forces in myelination and repair: a question of balance?Suppression of spinal connexin 43 expression attenuates mechanical hypersensitivity in rats after an L5 spinal nerve injury.Expression and functional significance of SOCS-1 and SOCS-3 in astrocytesSphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes.A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood PlasmaMechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disabilityExpression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors.Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins.Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesisAstroglial-axonal interactions during early stages of myelination in mixed cultures using in vitro and ex vivo imaging techniquesPoly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures.Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosisDemyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxicationGlia Disease and Repair-RemyelinationAstrocyte Activation via Stat3 Signaling Determines the Balance of Oligodendrocyte versus Schwann Cell Remyelination
P2860
Q24615946-262AEE7D-4627-4AB8-ADA3-BD2C5F48B81CQ26739719-D6EBB783-D956-45A8-9AE9-6D07FA845143Q26764727-40F60F6B-EE17-4341-9E56-F3EFF217FED9Q26772359-C032A48C-EA08-4DC3-B431-5612EA19D01AQ26779177-4E6D24EA-CA21-48AC-A552-EFDF8439206EQ26782843-14CCBA3C-8B7A-41E2-BBCD-D94F1882D558Q26861132-8794FC4A-6AF1-466A-BBEF-727636941B9AQ27000682-D19A26E8-8AD1-463E-9282-D48C9A15E951Q27010398-1B5049B3-E2C2-4497-B4A9-58F40D00967EQ28282324-52C067CD-D6F6-422E-AE88-DEA63104A494Q28283441-9BEB3E0C-BC26-463E-BD0C-5F02B03963CFQ28387740-52AD3D1E-6530-4C01-9B11-D067B1F7909FQ28388593-C16E5EB0-422E-4AC3-9C12-C49CCE0DF6D2Q28389410-322D57F6-1BB3-4F4C-A361-CFF0CDFB7B5CQ28391993-D5CAC085-A9F8-4FD5-B98D-EC2F2B9B2BE5Q28566413-B364A015-4FF5-4764-9B60-FFFCEDA9D108Q28567332-08E745B0-EAEA-4599-BAC5-C2A045737ED2Q29248440-EE43D2CD-48EC-4B94-A842-A90BB24237FDQ33335156-0F17DAAE-36E4-4010-B9DF-10A6CAB32C4BQ33508686-BE9C4CB8-19C9-4F7D-B832-5575FD483809Q33557637-A57E0184-F832-4865-A6F0-8C371ED0C3BEQ33717808-97A1C532-0EAE-4356-BC0C-570844DA7782Q33756197-F37F72A5-D9F6-4FE7-9F4E-FEE0E3ED452EQ33799866-2DE3F80E-C4C9-452C-B36E-C1129FA8E809Q33881977-64411877-76B4-4B0D-8105-523A10B58EBEQ33882403-2FD8F6FE-EBBE-4132-A9C3-25B4349008C9Q34077622-6B59058E-E3EE-46D7-96DF-A7A36E7F3A7BQ34310122-2B4AC503-6391-40A7-8C41-D2F06AE0DB76Q34359503-D68CEB5D-F72E-4116-A8FB-8E62C0C8B45AQ34427836-8256F415-C14E-4565-9566-E548451207B0Q34580168-1C465766-C90B-46CB-BD6E-3010B2980495Q34677050-E04CBF75-912F-4324-A159-2FC4A1CA50D4Q34837559-498F822F-1178-4B70-806A-8DD8B3CD3A3DQ35123174-75758794-49C6-4C74-A112-9BDE9B0196E2Q35179480-79746C6B-84D4-4742-B5ED-D09119158CBEQ35184144-547953BA-F43E-4B1D-8CA2-518D57384A88Q35577914-59DDD57E-C29E-4502-BA63-BAFDEDBC13ADQ35592803-634BBD9F-FC62-447B-886A-7F536330090CQ35795587-0C655CAA-8385-4C6F-AB60-F926740EBC3FQ36134459-47289A53-1ED7-4F6E-865A-3E59DA5C44F3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Astrocytes--friends or foes in multiple sclerosis?
@en
type
label
Astrocytes--friends or foes in multiple sclerosis?
@en
prefLabel
Astrocytes--friends or foes in multiple sclerosis?
@en
P2860
P356
P1433
P1476
Astrocytes--friends or foes in multiple sclerosis?
@en
P2093
Catherine Lubetzki
Gabrièle Piaton
P2860
P304
P356
10.1002/GLIA.20546
P577
2007-10-01T00:00:00Z